Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Pound the table

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Dec 13, 2022 10:10am

65 Views

Post# 35168243

Pound the table

I'm saying it's stupid because I haven't eard from anybody overthere, I haven't felt the hanger and table pounding that should come out of the company. Show the market you this this is stupid and do nothing and have them think Thera is worth 1$. And yess confirm that by secercising and selling you shares maybe.

<< Previous

Bullboard Posts

Next >>

NervGen: Are amazing human trial results leaking out?